The Cali Fund, set up to raise $1bn a year for biodiversity from drug companies, remains near empty

Big pharmaceutical companies have been accused of “free-riding on nature”, after a landmark biodiversity fund that invites businesses to put some of their profits back into conservation was left virtually empty.

The Cali Fund set out to raise $1bn (£750m) annually, by asking companies that profit from nature’s genetics to contribute towards conservation in low-income countries. But more than 18 months after the fund was launched, it remains far below this target.

Continue reading...

© Photograph: Rebecca Cole/The Guardian

© Photograph: Rebecca Cole/The Guardian

© Photograph: Rebecca Cole/The Guardian

The Cali Fund, set up to raise $1bn a year for biodiversity from drug companies, remains near empty

Big pharmaceutical companies have been accused of “free-riding on nature”, after a landmark biodiversity fund that invites businesses to put some of their profits back into conservation was left virtually empty.

The Cali Fund set out to raise $1bn (£750m) annually, by asking companies that profit from nature’s genetics to contribute towards conservation in low-income countries. But more than 18 months after the fund was launched, it remains far below this target.

Continue reading...

© Photograph: Rebecca Cole/The Guardian

© Photograph: Rebecca Cole/The Guardian

© Photograph: Rebecca Cole/The Guardian

In the early 5th century, a woman of high rank was buried beside an old Roman posting station on the Via Augusta, in what is now the province of Castellón. Her grave held a glass cup and two gold pins in a style from the Danube region. Her brother died in Mérida, the Roman city […]